Stocks · Health care · Orthopedic, Prosthetic & Surgical Appliances & Supplies

Edwards Lifesciences

EW Clue Score50
United States Fiscal year ends December CIK 0001099800 Results filed 4 Nov 2026

What the insiders did Mostly scheduled

Insider
Date
Role
Action
Shares
Price
Amount
Bernard J Zovighian
17 Jun 2026
CEO
Sold on a plan indirect
523
$87.92
$45.98K
Bernard J Zovighian
12 May 2026
CEO
Sold on a plan indirect
35,506
$77.92
$2.77M
Bernard J Zovighian
12 May 2026
CEO
Sold on a plan indirect
845
$78.40
$66.25K
Bernard J Zovighian
10 Dec 2025
CEO
Sold on a plan indirect
3,863
$83.45
$322.37K
Bernard J Zovighian
3 Jun 2025
CEO
Sold on a plan indirect
967
$77.32
$74.77K
Donald E Bobo Jr
2 Jun 2025
CVP,Strategy/Corp Development
Sold on a plan
2,570
$77.40
$198.91K
Bernard J Zovighian
30 May 2025
CEO
Sold on a plan indirect
16,099
$77.21
$1.24M
Larry L Wood
5 Nov 2024
Global President TAVR & Surg
Sold on a plan
25,000
$65.91
$1.65M
Bernard J Zovighian
30 May 2024
CEO
Sold on a plan
8,617
$87.68
$755.54K
Showing 250 of 966 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 915
Amendments (4/A) skipped 2
Filings about a different issuer 1
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 9
Sales straight out of an exercise 844
Sales at will 104
Transactions with no price 0
Shares from compensation/vesting 13,160,180
Sales filed before the plan box existed 77
History held since 3 Oct 2006